Welcome to LookChem.com Sign In|Join Free
  • or
7-Bromophenanthridine is a chemical compound belonging to the phenanthridine family, characterized by its molecular formula C13H9BrN and a molecular weight of 256.12 g/mol. It is a white crystalline solid with a melting point of 90-92°C. This halogenated derivative of phenanthridine is synthesized by introducing a bromine atom at the 7th position of the phenanthridine nucleus. 7-Bromophenanthridine is primarily used as an intermediate in the synthesis of various pharmaceuticals, agrochemicals, and other organic compounds. Due to its unique chemical structure, it exhibits interesting properties and reactivity, making it a valuable building block in organic synthesis.

2169-31-5

Post Buying Request

2169-31-5 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

2169-31-5 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 2169-31-5 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 2,1,6 and 9 respectively; the second part has 2 digits, 3 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 2169-31:
(6*2)+(5*1)+(4*6)+(3*9)+(2*3)+(1*1)=75
75 % 10 = 5
So 2169-31-5 is a valid CAS Registry Number.

2169-31-5Upstream product

2169-31-5Downstream Products

2169-31-5Relevant academic research and scientific papers

Chiral and Regenerable NAD(P)H Models Enabled Biomimetic Asymmetric Reduction: Design, Synthesis, Scope, and Mechanistic Studies

Luo, Gen,Luo, Yi,Wang, Jie,Zhao, Yanan,Zhao, Zi-Biao,Zhou, Yong-Gui,Zhu, Zhou-Hao

, (2020)

The coenzyme NAD(P)H plays an important role in electron as well as proton transmission in the cell. Thus, a variety of NAD(P)H models have been involved in biomimetic reduction, such as stoichiometric Hantzsch esters and achiral regenerable dihydrophenantheridine. However, the development of a general and new-generation biomimetic asymmetric reduction is still a long-term challenge. Herein, a series of chiral and regenerable NAD(P)H models with central, axial, and planar chiralities have been designed and applied in biomimetic asymmetric reduction using hydrogen gas as a terminal reductant. Combining chiral NAD(P)H models with achiral transfer catalysts such as Br?nsted acids and Lewis acids, the substrate scope could be also expanded to imines, heteroaromatics, and electron-deficient tetrasubstituted alkenes with up to 99% yield and 99% enantiomeric excess (ee). The mechanism of chiral regenerable NAD(P)H models was investigated as well. Isotope-labeling reactions indicated that chiral NAD(P)H models were regenerated by the ruthenium complex under hydrogen gas first, and then the hydride of NAD(P)H models was transferred to unsaturated bonds in the presence of transfer catalysts. In addition, density functional theory calculations were also carried out to give further insight into the transition states for the corresponding transfer catalysts.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 2169-31-5